ALCON EYE CARE UK LIMITED

Company Registration Number:
00809238 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2025

Period of accounts

Start date: 1 January 2025

End date: 31 December 2025

ALCON EYE CARE UK LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

ALCON EYE CARE UK LIMITED

Directors' report period ended 31 December 2025

The directors present their report with the financial statements of the company for the period ended 31 December 2025

Principal activities of the company

The principal activity of the Company is the sale and distribution of healthcare and consumer products for the eye, including contact lenses, contact lens solutions, dry eye ocular health solutions, intra ocular lenses, surgical consumable and medical equipment for eye related surgery.

Political and charitable donations

Alcon’s charitable donations are centralized in the Alcon Foundation and Alcon Cares in Fort Worth, Texas. The Company had no donations in 2025 (2024: £nil)



Directors

The directors shown below have held office during the whole of the period from
1 January 2025 to 31 December 2025

R. Henry
X. Romeu
O. Kostetskaya


Secretary R. Weston

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
22 June 2026

And signed on behalf of the board by:
Name: X. Romeu
Status: Director

ALCON EYE CARE UK LIMITED

Profit And Loss Account

for the Period Ended 31 December 2025

2025 2024


£

£
Turnover: 177,861 172,168
Cost of sales: ( 136,921 ) ( 128,741 )
Gross profit(or loss): 40,940 43,427
Distribution costs: ( 35,282 ) ( 35,844 )
Administrative expenses: ( 4,574 ) ( 6,689 )
Other operating income: 9,476 7,064
Operating profit(or loss): 10,560 7,958
Interest receivable and similar income: 148 238
Interest payable and similar charges: ( 743 ) ( 608 )
Profit(or loss) before tax: 9,965 7,588
Tax: ( 2,539 ) ( 1,907 )
Profit(or loss) for the financial year: 7,426 5,681

ALCON EYE CARE UK LIMITED

Balance sheet

As at 31 December 2025

Notes 2025 2024


£

£
Fixed assets
Tangible assets: 3 5,477 2,799
Investments: 4 9,436 9,436
Total fixed assets: 14,913 12,235
Current assets
Stocks: 5 27,312 22,542
Debtors: 6 39,981 44,402
Cash at bank and in hand: 152 3,876
Total current assets: 67,445 70,820
Prepayments and accrued income: 7,315 7,092
Creditors: amounts falling due within one year: 7 ( 25,247 ) ( 22,871 )
Net current assets (liabilities): 49,513 55,041
Total assets less current liabilities: 64,426 67,276
Creditors: amounts falling due after more than one year: 8 ( 14,307 ) ( 14,435 )
Provision for liabilities: ( 134 ) ( 159 )
Total net assets (liabilities): 49,985 52,682
Capital and reserves
Called up share capital: 550 550
Profit and loss account: 49,435 52,132
Total Shareholders' funds: 49,985 52,682

The notes form part of these financial statements

ALCON EYE CARE UK LIMITED

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 22 June 2026
and signed on behalf of the board by:

Name: X. Romeu
Status: Director

The notes form part of these financial statements

ALCON EYE CARE UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

    Turnover policy

    Revenue represents amounts received and receivable for goods and services invoiced in the UK and overseas net of value added tax and other related taxes. All revenue is recognised at the date of delivery and client acceptance. All revenue is recognised after the netting off of discounts and rebates. Revenue is derived from two franchises: the sale of consumer products for the eye and the sale of equipment for the eye related surgeries comprising into one revenue stream.

    Tangible fixed assets depreciation policy

    All tangible assets are carried at historical purchase cost less accumulated depreciation and impairment losses. Depreciation is calculated to write off the cost less estimated residual value of the assets on a straight-line basis over the expected useful economic lives, commencing when the assets are first brought into use.

    Valuation information and policy

    Foreign currency transactions during the year are translated into sterling at the rates of exchange in force at the time they arise. Both the functional and presentational currency are sterling. Monetary assets and liabilities denominated in foreign currencies are translated into sterling at rates of exchange ruling at the balance sheet date. Translation differences are taken to the profit and loss account.

    Other accounting policies

    The financial statements include other areas of judgment and accounting estimates. While these areas do not meet the definition of significant accounting estimates or accounting judgments, the recognition and measurement of certain material assets and liabilities, are based on assumptions and/or are subject to longer term uncertainties. These other areas of judgement and accounting estimate include the actuarial assumptions for the calculation of the defined benefit pension obligation. The Company has an obligation to pay defined pension benefits to certain employees. The cost of these benefits and present value of the obligation depends upon several factors, including life expectancy, salary increases and the discount rate on corporate bonds.

ALCON EYE CARE UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 217 210

ALCON EYE CARE UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 January 2025 326 8,610 681 9,617
Additions 3,988 3,988
Disposals ( 1,445 ) ( 1,445 )
Revaluations
Transfers
At 31 December 2025 326 11,153 681 12,160
Depreciation
At 1 January 2025 155 5,982 681 6,818
Charge for year 30 1,204 1,234
On disposals ( 1,369 ) ( 1,369 )
Other adjustments
At 31 December 2025 185 5,817 681 6,683
Net book value
At 31 December 2025 141 5,336 0 5,477
At 31 December 2024 171 2,628 0 2,799

ALCON EYE CARE UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

4. Fixed assets investments note

Included in tangible assets are assets amounting to £5,004k (2024: £4,678k) which are fully depreciated but still in use.

ALCON EYE CARE UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

5. Stocks

2025 2024
£ £
Stocks 27,312 22,542
Total 27,312 22,542

ALCON EYE CARE UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

6. Debtors

2025 2024
£ £
Trade debtors 30,510 30,272
Other debtors 9,471 14,130
Total 39,981 44,402
Debtors due after more than one year: 3,770 3,576

ALCON EYE CARE UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

7. Creditors: amounts falling due within one year note

2025 2024
£ £
Amounts due under finance leases and hire purchase contracts 1,248 951
Trade creditors 1,275 1,219
Taxation and social security 5,986 6,184
Accruals and deferred income 7,305 8,347
Other creditors 9,433 6,170
Total 25,247 22,871

ALCON EYE CARE UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

8. Creditors: amounts falling due after more than one year note

2025 2024
£ £
Amounts due under finance leases and hire purchase contracts 2,774 2,914
Other creditors 11,533 11,521
Total 14,307 14,435